Clayton Partners LLC grew its stake in shares of The Joint Corp. (NASDAQ:JYNT - Free Report) by 36.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 310,000 shares of the company's stock after buying an additional 82,447 shares during the quarter. Joint makes up 2.3% of Clayton Partners LLC's holdings, making the stock its 19th biggest holding. Clayton Partners LLC owned approximately 2.07% of Joint worth $3,295,000 as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. BNP Paribas Financial Markets raised its holdings in Joint by 5.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company's stock valued at $258,000 after buying an additional 1,156 shares during the last quarter. FMR LLC lifted its holdings in shares of Joint by 38.0% during the third quarter. FMR LLC now owns 10,787 shares of the company's stock worth $123,000 after purchasing an additional 2,971 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Joint by 9.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 36,204 shares of the company's stock worth $385,000 after purchasing an additional 3,029 shares during the last quarter. Geode Capital Management LLC increased its holdings in Joint by 1.1% in the third quarter. Geode Capital Management LLC now owns 291,581 shares of the company's stock valued at $3,336,000 after purchasing an additional 3,043 shares during the period. Finally, O Brien Greene & Co. Inc increased its holdings in Joint by 3.5% in the third quarter. O Brien Greene & Co. Inc now owns 119,620 shares of the company's stock valued at $1,368,000 after purchasing an additional 4,000 shares during the period. 76.88% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded Joint from a "buy" rating to a "hold" rating in a report on Monday.
Get Our Latest Research Report on JYNT
Joint Stock Performance
Shares of NASDAQ JYNT traded up $0.33 during midday trading on Thursday, reaching $12.76. The stock had a trading volume of 99,072 shares, compared to its average volume of 51,557. The company's 50 day moving average price is $11.16 and its 200 day moving average price is $11.16. The Joint Corp. has a twelve month low of $9.58 and a twelve month high of $17.82. The firm has a market cap of $191.20 million, a price-to-earnings ratio of -11.19 and a beta of 1.61.
About Joint
(
Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Stories

Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.